110 related articles for article (PubMed ID: 20433950)
1. Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab.
Ursini F; Naty S; Mazzei V; Spagnolo F; Grembiale RD
Int Immunopharmacol; 2010 Jul; 10(7):827-8. PubMed ID: 20433950
[No Abstract] [Full Text] [Related]
2. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
3. Aetiology of Kaposi's sarcoma: current understanding and implications for therapy.
Boshoff C; Weiss RA
Mol Med Today; 1997 Nov; 3(11):488-94. PubMed ID: 9430784
[TBL] [Abstract][Full Text] [Related]
4. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ
Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.
Monini P; Sgadari C; Grosso MG; Bellino S; Di Biagio A; Toschi E; Bacigalupo I; Sabbatucci M; Cencioni G; Salvi E; Leone P; Ensoli B
AIDS; 2009 Feb; 23(4):534-8. PubMed ID: 19169139
[TBL] [Abstract][Full Text] [Related]
6. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
Caterino-de-Araujo A; Magri MC; Manuel RC
J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
[TBL] [Abstract][Full Text] [Related]
7. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
[TBL] [Abstract][Full Text] [Related]
9. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
Sri JC; Tsai CL; Deng A; Gaspari AA
J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
[TBL] [Abstract][Full Text] [Related]
10. [Human herpesvirus-8 in Hungarian blood donors and in patients with Kaposi sarcoma].
Juhász A; Remenyik E; Hunyadi J; Gergely L
Orv Hetil; 1998 Dec; 139(50):3001-4. PubMed ID: 9876459
[TBL] [Abstract][Full Text] [Related]
11. Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents.
Kapusta MA; Dumont C
J Rheumatol; 2008 Oct; 35(10):2077-80. PubMed ID: 18843767
[No Abstract] [Full Text] [Related]
12. Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis.
Barozzi P; Potenza L; Riva G; Vallerini D; Quadrelli C; Bosco R; Morselli M; Forghieri F; Volzone F; Rossi G; Ferri C; Bonini C; Ciceri F; Bordignon C; Whitby D; Schulz TF; Torelli G; Luppi M
Semin Arthritis Rheum; 2009 Dec; 39(3):170-5. PubMed ID: 18639317
[TBL] [Abstract][Full Text] [Related]
13. Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience.
Voulgari PV; Venetsanopoulou AI; Epagelis EK; Alamanos Y; Takalou I; Drosos AA
Ann Rheum Dis; 2007 Feb; 66(2):270-1. PubMed ID: 17068063
[No Abstract] [Full Text] [Related]
14. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
15. Salivary human herpesvirus 8 shedding in renal allograft recipients with Kaposi's sarcoma.
Al-Otaibi LM; Ngui SL; Scully CM; Porter SR; Teo CG
J Med Virol; 2007 Sep; 79(9):1357-65. PubMed ID: 17607792
[TBL] [Abstract][Full Text] [Related]
16. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
[No Abstract] [Full Text] [Related]
17. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
18. Detection of HHV-8 DNA in a German patient with classical Kaposi's sarcoma may allow an estimation of the incubation period.
Kowalzick L; Hoffmann I; Neipel F; Walter H; Schlehaider UK; Pönnighaus JM
Eur J Dermatol; 1998 Sep; 8(6):432-4. PubMed ID: 9729052
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy.
Cohen CD; Horster S; Sander CA; Bogner JR
Ann Rheum Dis; 2003 Jul; 62(7):684. PubMed ID: 12810439
[No Abstract] [Full Text] [Related]
20. Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals.
Okroj M; Spiller OB; Korodi Z; Tedeschi R; Dillner J; Blom AM
Vaccine; 2007 Nov; 25(48):8102-9. PubMed ID: 17964697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
